| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 838 | 2021 |
| Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy C Minetti, F Sotgia, C Bruno, P Scartezzini, P Broda, M Bado, E Masetti, ... Nature genetics 18 (4), 365-368, 1998 | 778 | 1998 |
| Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities F Galbiati, JA Engelman, D Volonte, XL Zhang, C Minetti, M Li, H Hou, ... Journal of Biological Chemistry 276 (24), 21425-21433, 2001 | 568 | 2001 |
| Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder M Hirano, G Silvestri, DM Blake, A Lombes, C Minetti, E Bonilla, AP Hays, ... Neurology 44 (4), 721-721, 1994 | 495 | 1994 |
| Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue D Whitaker-Menezes, UE Martinez-Outschoorn, N Flomenberg, R Birbe, ... Cell cycle 10 (23), 4047-4064, 2011 | 359 | 2011 |
| STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy H Stamberger, M Nikanorova, MH Willemsen, P Accorsi, M Angriman, ... Neurology 86 (10), 954-962, 2016 | 335 | 2016 |
| Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both M Hirano, BR Ott, EC Raps, C Minetti, L Lennihan, NP Libbey, E Bonilla, ... Neurology 42 (11), 2082-2082, 1992 | 292 | 1992 |
| Caveolin-3 directly interacts with the C-terminal tail of β-dystroglycan: identification of a central WW-like domain within caveolin family members F Sotgia, JK Lee, K Das, M Bedford, TC Petrucci, P Macioce, ... Journal of Biological Chemistry 275 (48), 38048-38058, 2000 | 287 | 2000 |
| Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression M Pescatori, A Broccolini, C Minetti, E Bertini, C Bruno, A D'amico, ... The FASEB Journal 21 (4), 1210-1226, 2007 | 260 | 2007 |
| Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants E Baraldi, M Lanari, P Manzoni, GA Rossi, S Vandini, A Rimini, ... Italian journal of pediatrics 40, 1-13, 2014 | 257 | 2014 |
| Caveolinopathies: from the biology of caveolin-3 to human diseases E Gazzerro, F Sotgia, C Bruno, MP Lisanti, C Minetti European journal of human genetics 18 (2), 137-145, 2010 | 248 | 2010 |
| Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy JA Engelman, XL Zhang, F Galbiati, D Volonté, F Sotgia, RG Pestell, ... The American Journal of Human Genetics 63 (6), 1578-1587, 1998 | 243 | 1998 |
| Mutation in the CAV3 gene causes partial caveolin-3 deficiency and persistent elevated levels of serum creatine kinase I Carbone, C Bruno, F Sotgia, M Bado, P Broda, E Masetti, A Panella, ... Neurology 54 (6), 1373-1376, 2000 | 225 | 2000 |
| AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 224 | 2019 |
| Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases SE Woodman, F Sotgia, F Galbiati, C Minetti, MP Lisanti Neurology 62 (4), 538-543, 2004 | 222 | 2004 |
| Phenotypic heterogeneity of the 8344A> G mtDNA “MERRF” mutation M Mancuso, D Orsucci, C Angelini, E Bertini, V Carelli, GP Comi, C Minetti, ... Neurology 80 (22), 2049-2054, 2013 | 215 | 2013 |
| Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C): retention of LGMD-1C caveolin-3 mutants within the Golgi complex F Galbiati, D Volonté, C Minetti, JB Chu, MP Lisanti Journal of Biological Chemistry 274 (36), 25632-25641, 1999 | 207 | 1999 |
| Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy E Mercuri, E Bertini, S Messina, A Solari, A D'amico, C Angelozzi, ... Neurology 68 (1), 51-55, 2007 | 203 | 2007 |
| Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study E Mercuri, S Messina, C Bruno, M Mora, E Pegoraro, GP Comi, A D'Amico, ... Neurology 72 (21), 1802-1809, 2009 | 198 | 2009 |
| Dystrophinopathy in isolated cases of myopathy in females EP Hoffman, K Arahata, C Minetti, E Bonilla, LP Rowland, C Angelini, ... Neurology 42 (5), 967-967, 1992 | 193 | 1992 |
Michael P. Lisanti, MD-PhD, FRSA, FR...Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)Verified email at salford.ac.uk